Proficio Capital Partners LLC acquired a new position in shares of Oracle Corporation (NYSE:ORCL - Free Report) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 7,228 shares of the enterprise software provider's stock, valued at approximately $1,059,000.
Several other large investors have also recently bought and sold shares of ORCL. State Street Corp raised its stake in Oracle by 4.4% during the 4th quarter. State Street Corp now owns 76,527,759 shares of the enterprise software provider's stock worth $14,916,026,000 after buying an additional 3,216,915 shares during the period. Geode Capital Management LLC increased its position in shares of Oracle by 1.8% during the fourth quarter. Geode Capital Management LLC now owns 37,734,944 shares of the enterprise software provider's stock worth $7,328,754,000 after acquiring an additional 665,374 shares in the last quarter. Capital Research Global Investors increased its holdings in Oracle by 29.3% during the 4th quarter. Capital Research Global Investors now owns 30,137,126 shares of the enterprise software provider's stock worth $5,874,070,000 after purchasing an additional 6,826,299 shares in the last quarter. Morgan Stanley grew its holdings in shares of Oracle by 1.9% during the fourth quarter. Morgan Stanley now owns 27,125,099 shares of the enterprise software provider's stock worth $5,286,953,000 after buying an additional 495,146 shares in the last quarter. Finally, Norges Bank acquired a new stake in shares of Oracle in the fourth quarter valued at approximately $4,336,031,000. Institutional investors own 42.44% of the company's stock.
Oracle Stock Performance
Shares of ORCL opened at $140.99 on Wednesday. The firm's fifty day simple moving average is $139.73 and its two-hundred day simple moving average is $160.44. Oracle Corporation has a 12 month low of $114.50 and a 12 month high of $345.72. The stock has a market capitalization of $406.12 billion, a P/E ratio of 24.18, a price-to-earnings-growth ratio of 0.93 and a beta of 1.74. The company has a current ratio of 1.12, a quick ratio of 1.12 and a debt-to-equity ratio of 3.21.
Oracle (NYSE:ORCL - Get Free Report) last issued its earnings results on Wednesday, June 10th. The enterprise software provider reported $2.11 earnings per share for the quarter, topping analysts' consensus estimates of $1.96 by $0.15. Oracle had a return on equity of 58.62% and a net margin of 25.37%.The business had revenue of $19.18 billion during the quarter, compared to the consensus estimate of $19.10 billion. During the same period in the previous year, the company posted $1.70 earnings per share. The firm's revenue for the quarter was up 20.6% on a year-over-year basis. Oracle has set its Q1 2027 guidance at 1.720-1.760 EPS and its FY 2027 guidance at 8.050-8.050 EPS. As a group, analysts predict that Oracle Corporation will post 6.49 EPS for the current year.
Oracle Announces Dividend
The company also recently declared a quarterly dividend, which was paid on Friday, July 24th. Investors of record on Friday, July 10th were paid a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 1.4%. The ex-dividend date of this dividend was Friday, July 10th. Oracle's dividend payout ratio is 34.31%.
Oracle News Roundup
Here are the key news stories impacting Oracle this week:
- Positive Sentiment: Oracle reported $638 billion in remaining performance obligations at fiscal 2026 year-end, up 363% year over year. The backlog provides significant long-term revenue visibility, although management expects only 12% to convert to revenue within the next 12 months. Oracle Has $638 Billion of Contracted Backlog and a $430 Billion Stock
- Positive Sentiment: Analysts continue to point to Oracle’s cloud and AI growth potential. TD Cowen maintained a Buy rating despite reducing its price target to $240, while other commentary described ORCL as potentially undervalued relative to its cloud and AI opportunity. Oracle Slides as Cowen Cuts Target
- Positive Sentiment: Oracle Health expanded its Clinical AI Agent in the United States, adding automation for documentation, coding and chart-review workflows within electronic health records. The rollout could strengthen Oracle’s position in healthcare technology and support its broader AI strategy. Oracle Health Using Healthcare AI
- Neutral Sentiment: Oracle’s next quarterly report is approaching, and analysts expect another earnings beat based on its historical surprise record. Investors will focus on cloud growth, backlog conversion, capital spending and updated financing plans. Why Oracle Is Poised to Beat Earnings Estimates Again
- Negative Sentiment: Fiscal 2026 free cash flow was negative $23.7 billion as Oracle accelerated data-center investment. The company raised $43 billion in debt and expects to raise roughly $40 billion more in fiscal 2027, increasing sensitivity to higher interest rates and execution risk. Why Is Oracle Stock Down Today
- Negative Sentiment: TD Cowen’s target reduction highlighted concerns that spending is arriving before revenue, while a global bond selloff is pressuring highly leveraged AI infrastructure companies. Rising yields reduce the attractiveness of ORCL’s debt-funded expansion and future cash flows. Oracle Falls as Bond Selloff Tests AI Buildout
- Negative Sentiment: EU antitrust regulators are examining Oracle’s licensing practices, according to a Reuters source. A regulatory case similar to SAP’s could create compliance costs, concessions or restrictions on Oracle’s commercial model. Oracle Licensing Practices on EU Antitrust Radar
- Negative Sentiment: Renewed geopolitical tensions, higher global bond yields and broader technology-sector weakness further reduced investor risk appetite, adding pressure to ORCL alongside company-specific balance-sheet concerns. SoundHound AI, Fastly and Oracle Shares Plummet
Insider Activity
In related news, Vice Chairman Jeffrey Henley sold 400,000 shares of Oracle stock in a transaction on Wednesday, June 24th. The shares were sold at an average price of $159.16, for a total value of $63,664,000.00. Following the completion of the sale, the insider owned 400,000 shares of the company's stock, valued at approximately $63,664,000. This trade represents a 50.00% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 40.90% of the stock is currently owned by corporate insiders.
Wall Street Analysts Forecast Growth
A number of analysts recently issued reports on ORCL shares. BTIG Research reaffirmed a "buy" rating and issued a $400.00 target price on shares of Oracle in a research report on Friday, June 5th. Guggenheim reissued a "buy" rating on shares of Oracle in a report on Thursday, July 23rd. Citigroup restated a "buy" rating on shares of Oracle in a research report on Wednesday, August 26th. Bank of America upped their price objective on shares of Oracle from $200.00 to $240.00 and gave the stock a "buy" rating in a research report on Tuesday, June 9th. Finally, Evercore reaffirmed an "outperform" rating and issued a $245.00 target price on shares of Oracle in a report on Monday, June 8th. Two research analysts have rated the stock with a Strong Buy rating, twenty-eight have assigned a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Oracle has a consensus rating of "Moderate Buy" and a consensus target price of $262.39.
Read Our Latest Stock Report on Oracle
About Oracle
(
Free Report)
Oracle Corporation is a multinational technology company that develops and sells database software, cloud engineered systems, enterprise software applications and related services. The company is widely known for its flagship Oracle Database and a portfolio of enterprise-grade software products that support data management, application development, analytics and middleware. Over recent years Oracle has expanded its focus to include cloud infrastructure and cloud applications, positioning itself as a provider of both platform and software-as-a-service solutions for large organizations.
Oracle's product and service offerings include Oracle Database and the Autonomous Database, Oracle Cloud Infrastructure (OCI), enterprise resource planning (ERP), human capital management (HCM) and supply chain management (SCM) cloud applications (often grouped under Oracle Fusion Cloud Applications), middleware such as WebLogic, and developer technologies including Java and MySQL.
Read More
Want to see what other hedge funds are holding ORCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Oracle Corporation (NYSE:ORCL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Oracle, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Oracle wasn't on the list.
While Oracle currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report